Latest Blog Posts

FDA May Add New Warnings to Breast Implant Products

by Staff Blogger | October 29th, 2019

The U.S. Food and Drug Administration (FDA) recently announced that it is considering new labeling recommendations for breast implants that will help patients better understand the risks of the product and the surgical procedures involved. In a press release, the agency indicated that it has heard from many women who said they weren’t fully informed

Read More

Avoid These 3 Common Defective Medical Device Mistakes

by Staff Blogger | July 30th, 2019

Medical devices are designed to alleviate symptoms, reduce pain, and improve quality of life. But like all manufactured products, medical devices are subject to variances in quality. In addition, some medical devices may be inherently flawed due to poor designs or the use of cut-rate components that break down inside patients’ bodies. If you or

Read More

FDA Announces Class I Recall of Defective Surgical Stapler and Staples

by Staff Blogger | July 9th, 2019

In April 2019, we discussed the U.S. Food and Drug Administration’s (FDA) findings of serious injuries and even deaths related to malfunctioning surgical staplers and misapplied surgical staples. In May 2019, the FDA announced that Ethicon was recalling its circular staplers due to their tendency to misfire and to fail to completely form staples, both

Read More

Fentanyl Patches Recalled Due to Potentially Life-Threatening Labeling Error

by Staff Blogger | June 11th, 2019

At Ferrer, Poirot & Wansbrough, we’ve helped many people who were harmed by fentanyl pain patches. These transdermal patches are designed to relieve chronic pain, but some manufacturing defects have resulted in large quantities of the drug being released into wearers’ bloodstreams. Because fentanyl is 80 times more potent than morphine, even tiny overdoses of

Read More